Dyne Therapeutics, Inc. (DYN)
NASDAQ: DYN · Real-Time Price · USD
14.56
+0.61 (4.37%)
At close: Oct 8, 2025, 4:00 PM EDT
14.84
+0.28 (1.92%)
After-hours: Oct 8, 2025, 7:55 PM EDT
Dyne Therapeutics Market Cap
Dyne Therapeutics has a market cap or net worth of $2.07 billion as of October 8, 2025. Its market cap has decreased by -43.62% in one year.
Market Cap
2.07B
Enterprise Value
1.51B
1-Year Change
-43.62%
Ranking
Category
Stock Price
$14.56
Market Cap Chart
Since the IPO on September 17, 2020, Dyne Therapeutics's market cap has increased from $790.90M to $2.07B, an increase of 161.90%. That is a compound annual growth rate of 20.97%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 1.98B | -17.23% |
| Dec 31, 2024 | 2.40B | 193.72% |
| Dec 29, 2023 | 816.30M | 35.12% |
| Dec 30, 2022 | 604.12M | -0.31% |
| Dec 31, 2021 | 606.03M | -36.50% |
| Dec 31, 2020 | 954.35M | 20.67% |
| Sep 17, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 759.23B |
| Johnson & Johnson | 456.84B |
| AbbVie | 408.50B |
| UnitedHealth Group | 335.03B |
| AstraZeneca | 266.28B |
| Novo Nordisk | 265.74B |
| Novartis AG | 257.26B |
| Abbott Laboratories | 233.69B |